Beranda › Penyakit Autoimun
Uji klinis Penyakit Autoimun yang merekrut di AS
76 studi untuk Penyakit Autoimun merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX21 studi
- Washington, DC19 studi
- New York City, NY19 studi
- Philadelphia, PA16 studi
- Durham, NC15 studi
- Boston, MA13 studi
- Los Angeles, CA12 studi
- Chicago, IL12 studi
- Dallas, TX9 studi
- Cleveland, OH8 studi
- Atlanta, GA8 studi
- Milwaukee, WI8 studi
- Portland, OR8 studi
- Cedar Rapids, IA7 studi
- Seattle, WA7 studi
- Pittsburgh, PA7 studi
- San Francisco, CA7 studi
- Orange, CA7 studi
- Ann Arbor, MI6 studi
- Memphis, TN6 studi
- Salt Lake City, UT6 studi
- Louisville, KY6 studi
- The Bronx, NY6 studi
- Jacksonville, FL6 studi
- Baltimore, MD6 studi
- Miami, FL6 studi
- Mountain View, CA6 studi
- Kansas City, KS6 studi
- Rochester, MN6 studi
- San Diego, CA5 studi
- Aurora, CO5 studi
- Sacramento, CA5 studi
- New Haven, CT5 studi
- Nashville, TN5 studi
- St. Louis, MO4 studi
- Phoenix, AZ4 studi
- Kansas City, MO4 studi
- Indianapolis, IN4 studi
- Greenville, NC4 studi
- Charleston, SC4 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona6 studi
- Arkansas3 studi
- California27 studi
- Colorado8 studi
- Connecticut5 studi
- Distrik Columbia6 studi
- Florida20 studi
- Georgia10 studi
- Illinois14 studi
- Indiana4 studi
- Iowa7 studi
- Kansas7 studi
- Kentucky8 studi
- Maryland21 studi
- Massachusetts16 studi
- Michigan9 studi
- Minnesota9 studi
- Missouri7 studi
- Nebraska3 studi
- New Jersey5 studi
- New York24 studi
- North Carolina18 studi
- Ohio13 studi
- Oklahoma4 studi
- Oregon9 studi
- Pennsylvania21 studi
- South Carolina4 studi
- Tennessee10 studi
- Texas22 studi
- Utah7 studi
- Virginia6 studi
- Washington8 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00867269NIAID Centralized Sequencing Protocol
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 100 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03206099Natural History of Bronchiectasis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 5 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00943514Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06817889Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Menerima pesertaFase 2
Usia 4 hingga 69 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04339777Environmental Risk Factors for the Anti-synthetase Syndrome
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 4 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT02579967Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07621809Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04097561Secukinumab Open Label Roll-over Extension Protocol
Menerima pesertaFase 4
Usia 6 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04638647A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07541287Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Menerima pesertaStudi observasional
Hingga usia 99 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00001350Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Menerima pesertaStudi observasional
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00246857Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Menerima pesertaFase 2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00977977Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07513181A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Menerima pesertaFase 2
Usia 16 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07328581RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Menerima pesertaFase 2/3
Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05671757METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Menerima pesertaFase 2
Usia 18 hingga 69 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07699380A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07059000A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07182227Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.